Covid Inquiry: Mistake not to consider range of pandemics – David Cameron
David Cameron says “group think” meant government focused on flu pandemics, rather than other diseases.
Similar Posts
SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’
The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million by making “false and misleading” statements about one of…
What are nitazenes? What to know about the drug that can be 10 times as potent as fentanyl
Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports 01:13 An overdose death in Colorado has been linked to a new formulation of nitazenes, a class of powerful opioid analgesics being increasingly seen in the illicit drug market….
Eli Lilly launches website to help patients get weight loss drugs
Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a move, the company says, that will improve access to the extremely popular and effective drugs, including its recently approved drug, Zepbound. The new website, called LillyDirect, joins a growing list of platforms like Weight…
Possible Ozempic side effects including hair loss and suicidal thoughts probed by FDA
The Food and Drug Administration is looking into whether three possible health issues or side effects, including hair loss and thoughts of suicide, might be linked to a group of medications that have boomed in popularity for their use in weight loss, including Ozempic, Wegovy, Mounjaro and Zepbound. The probe into these issues was disclosed…
Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…
This $16 French Moisturizer Is Amazon’s Best-Kept Beauty Secret
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. We see a lot of beauty and skin care products…
